Rhinomed, Inc
Rhinomed is a listed (ASX: RNO, OTCQB: RHNMF) medical technology company that specializes in wearable nasal technology as a novel way to address problems with breathing, sleep, and nasal congestion (e.g. due to sleep apnea, allergy, colds, and flu).
Rhinomed’s products are Class 1 medical devices listed for sale in the US (FDA), Canada (MDEL), Europe (CE Mark), the UK (MHRA), and Australia (TGA).
Rhinomed invests in furthering knowledge of the role played by the nose, upper airways, and olfactory system in maintaining health and wellness, with our product pipeline now extending to sampling, diagnostics, and nasal drug delivery. Our comfortable and user-friendly self-collection nasal swabs, Rhinoswab and Rhinoswab Junior are clinically validated and preferred by children, adults, and nurses for their superior user experience.